Sun Pharma Advanced Research Company Limited (SPARC) is a clinical-stage biopharmaceutical company in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic. It focuses on the research and development of pharmaceutical products in India and internationally, with a therapeutic emphasis on oncology and immunology. SPARC's pipeline includes Vodobatinib (SCO-088) and Vibozilimod (SCD-044), both in phase 2 clinical trials for various conditions, alongside other products in development.
Candlesticks, moving averages, Bollinger Bands, Supertrend, and RSI/MACD/ADX in their own panels -- free for any NSE stock or index